PT858324E - Processo de granulacao aquosa da claritromicina - Google Patents

Processo de granulacao aquosa da claritromicina

Info

Publication number
PT858324E
PT858324E PT96937699T PT96937699T PT858324E PT 858324 E PT858324 E PT 858324E PT 96937699 T PT96937699 T PT 96937699T PT 96937699 T PT96937699 T PT 96937699T PT 858324 E PT858324 E PT 858324E
Authority
PT
Portugal
Prior art keywords
claritromycin
aqueous granulation
granulation process
macrolide antibiotic
carbomer
Prior art date
Application number
PT96937699T
Other languages
English (en)
Inventor
Azita Saleki-Gerhard
Ernest R Keske
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of PT858324E publication Critical patent/PT858324E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PT96937699T 1995-11-01 1996-10-18 Processo de granulacao aquosa da claritromicina PT858324E (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US715095P 1995-11-01 1995-11-01
US08/722,288 US5919489A (en) 1995-11-01 1996-10-09 Process for aqueous granulation of clarithromycin
PCT/US1996/016794 WO1997016174A1 (en) 1995-11-01 1996-10-18 Process for aqueous granulation of clarithromycin

Publications (1)

Publication Number Publication Date
PT858324E true PT858324E (pt) 2003-10-31

Family

ID=26676595

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96937699T PT858324E (pt) 1995-11-01 1996-10-18 Processo de granulacao aquosa da claritromicina

Country Status (13)

Country Link
US (1) US5919489A (pt)
EP (1) EP0858324B1 (pt)
JP (1) JP4334015B2 (pt)
KR (1) KR100524202B1 (pt)
AT (1) ATE241963T1 (pt)
AU (1) AU706837B2 (pt)
CA (1) CA2235607C (pt)
DE (1) DE69628575T2 (pt)
DK (1) DK0858324T3 (pt)
ES (1) ES2200075T3 (pt)
IL (1) IL123571A (pt)
PT (1) PT858324E (pt)
WO (1) WO1997016174A1 (pt)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6010718A (en) * 1997-04-11 2000-01-04 Abbott Laboratories Extended release formulations of erythromycin derivatives
US6551616B1 (en) 1997-04-11 2003-04-22 Abbott Laboratories Extended release formulations of erythromycin derivatives
BR0011345A (pt) * 1999-06-11 2002-04-23 Ranbaxy Lab Ltd Composições com sabor mascarado
IN191239B (pt) 1999-06-11 2003-10-11 Ranbaxy Lab Ltd
EP1231896A4 (en) * 1999-11-16 2003-07-09 Ranbaxy Lab Ltd MASK TASTE ORAL COMPOSITIONS
US6565882B2 (en) 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
HUP0302466A2 (hu) * 2000-02-29 2003-11-28 Teva Pharmaceutical Industries Ltd. Eljárások clarithromycin, clarithromycin intermedier, gyakorlatilag oximmentes clarithromycin és ezt tartalmazó gyógyszerkészítmény előállítására
BR0109544A (pt) * 2000-03-28 2003-06-10 Biochemie Gmbh Partìculas granuladas com sabor ocultado
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6541014B2 (en) 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
DE10133546A1 (de) * 2001-07-11 2003-03-06 Petra Bastian Mischkomplexe zur Maskierung bitter schmeckender Substanzen
FR2827517B1 (fr) * 2001-07-23 2003-10-24 Bioalliance Pharma Systemes therapeutiques bioadhesifs a liberation prolongee
JP2004537566A (ja) * 2001-08-01 2004-12-16 ブリストル−マイヤーズ　スクイブ　カンパニー 味マスキング組成物
US20040043073A1 (en) * 2002-06-14 2004-03-04 Chih-Ming Chen Pharmaceutical compositions for drugs having pH-dependent solubility
US20060083759A1 (en) * 2002-07-17 2006-04-20 Aleksander Resman Stabilization of the profile of release of active substances from a formulation
EP1417958A1 (en) * 2002-11-08 2004-05-12 Pari GmbH Wet granulation process
US7476403B2 (en) * 2003-06-16 2009-01-13 Andrx Pharmaceuticals, Llc Oral extended-release composition
CA2533358C (en) 2003-07-21 2014-03-11 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
WO2005009365A2 (en) 2003-07-21 2005-02-03 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
AU2004258953B2 (en) 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
US8758820B2 (en) 2003-08-11 2014-06-24 Shionogi Inc. Robust pellet
JP2007502294A (ja) 2003-08-12 2007-02-08 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
US8246996B2 (en) 2003-08-29 2012-08-21 Shionogi Inc. Antibiotic product, use and formulation thereof
JP2007513869A (ja) 2003-09-15 2007-05-31 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
CN1889931A (zh) * 2003-12-04 2007-01-03 辉瑞产品公司 利用挤压器制备优选含泊洛沙姆和甘油酯的多重粒子阿奇霉素组合物的喷雾－冻凝方法
WO2005053639A2 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Controlled release multiparticulates formed with dissolution enhancers
US6984403B2 (en) * 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
BRPI0416534A (pt) * 2003-12-04 2007-01-09 Pfizer Prod Inc composições multiparticuladas com estabilidade melhorada
EP1694304A2 (en) * 2003-12-04 2006-08-30 Pfizer Products Inc. Azithromycin multiparticulate dosage forms by liquid-based processes
ATE399536T1 (de) * 2003-12-04 2008-07-15 Pfizer Prod Inc Verfahren zur herstellung von pharmazeutischen multiteilchenförmigen produkten
CA2549225A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Spray-congeal process using an extruder for preparing multiparticulate crystalline drug compositions containing preferably a poloxamer and a glyceride
RU2268051C2 (ru) * 2003-12-15 2006-01-20 Закрытое акционерное общество "Фармацевтическое предприятие "Оболенское" Лекарственная форма, обладающая бактериостатическим действием, и способ ее изготовления
US7943585B2 (en) 2003-12-22 2011-05-17 Sandoz, Inc. Extended release antibiotic composition
US8715727B2 (en) 2004-07-02 2014-05-06 Shionogi Inc. Tablet for pulsed delivery
CN1883456B (zh) * 2005-06-20 2010-12-15 常州市第四制药厂有限公司 掩味药物颗粒及其制备方法和用途
CA2614412A1 (en) * 2005-07-07 2007-01-18 Elan Pharma International, Limited Nanoparticulate clarithromycin formulations
US20070048364A1 (en) * 2005-08-04 2007-03-01 Yingxu Peng Free flowing granules containing carbomer
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
EP1837020A1 (en) 2006-03-24 2007-09-26 Bioalliance Pharma Mucosal bioadhesive slow release carrier for delivering active principles
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
US20070286903A1 (en) * 2006-06-13 2007-12-13 Becicka Brian T Composition and method for taste masking
EP2030613A1 (en) 2007-08-17 2009-03-04 Abbott GmbH & Co. KG Preparation of compositions with essentially noncrystalline embedded macrolide antibiotics
JP5585920B2 (ja) * 2010-12-27 2014-09-10 富田製薬株式会社 粒子状製剤
CN102813633A (zh) * 2011-06-10 2012-12-12 塔科敏斯基制药厂波尔法合资公司 用湿法制粒制备包含大环内酯类抗生素的药物组合物的方法
RU2692469C1 (ru) * 2018-06-25 2019-06-25 ООО "Новые Антибиотики" Лекарственное средство для лечения и предупреждения возникновения осложнений, связанных с химиотерапией и рентгенотерапией, а также состояний, связанных с повышенной проницаемостью кишки
CN112566635A (zh) * 2018-08-10 2021-03-26 日本脏器制药株式会社 粒状组合物及其制造方法
CN118511875A (zh) * 2024-05-17 2024-08-20 镇江先锋植保科技有限公司 一种高性能水分散粒剂的制备方法及一种自冷却挤压造粒机

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4608278A (en) * 1983-06-22 1986-08-26 The Ohio State University Research Foundation Small particule formation and encapsulation
US4808411A (en) * 1987-06-05 1989-02-28 Abbott Laboratories Antibiotic-polymer compositions

Also Published As

Publication number Publication date
WO1997016174A1 (en) 1997-05-09
MX9803480A (es) 1998-09-30
KR100524202B1 (ko) 2006-07-06
JPH11514646A (ja) 1999-12-14
DK0858324T3 (da) 2003-09-29
JP4334015B2 (ja) 2009-09-16
AU706837B2 (en) 1999-06-24
DE69628575D1 (de) 2003-07-10
EP0858324B1 (en) 2003-06-04
CA2235607A1 (en) 1997-05-09
DE69628575T2 (de) 2004-04-29
CA2235607C (en) 2003-05-13
US5919489A (en) 1999-07-06
AU7517696A (en) 1997-05-22
KR19990067265A (ko) 1999-08-16
ES2200075T3 (es) 2004-03-01
ATE241963T1 (de) 2003-06-15
EP0858324A1 (en) 1998-08-19
IL123571A (en) 2005-07-25
IL123571A0 (en) 1998-10-30

Similar Documents

Publication Publication Date Title
PT858324E (pt) Processo de granulacao aquosa da claritromicina
BR9600993B1 (pt) compostos de ácido fosfomonoéster nucléicos.
ES2124373T3 (es) Procedimiento para la preparacion de derivados del acido n-acil-n,n',n'-etilendiamintriacetico.
AU7839594A (en) Strategy for the production of rna from immobilized templates
RU94026253A (ru) Композиция из эластомерных полипропиленов и неолефиновых термопластов, способ их получения
ES2098140T3 (es) Liosferas que contienen gonadotropina.
ES2166010T3 (es) Produccion de acrilato de amonio.
FR2709812B1 (fr) Procédé de combustion.
BR9205854A (pt) Composiçoes de mistura curavel por UV e processos.
DE69425534D1 (de) Mischverfahren zur Formulierung von Detergentien
DE69632135D1 (de) Prozess zur hydrierenden entschwefelung.
BR9813079A (pt) Processo para a preparação de um antibiótico beta-lactama
ES2122647T3 (es) Granulado polienzimatico asi como su fabricacion.
BR9101118A (pt) Produto contendo um ou mais veiculos de enzimas e anticorpos ou fragmentos de anticorpos,e processo para atacar um alvo
WO2001062765A3 (en) Small molecule modulators of g protein-coupled receptor six
PT633928E (pt) Microrganismos processo de preparacao e utilizacao
PT102202A (pt) Processo para a purificacao de roxitromicina
BR9710386B1 (pt) processo de preparação de um composto e processo de transformação do composto.
TR200002293T2 (tr) Farmasötik bileşimler.
BR9914775A (pt) Processo quìmico para preparação deintermediários
RU98122051A (ru) Способ получения удобрения с биоактивной добавкой
FR2731218B1 (fr) Procede de preparation de l'acide 3-chloropropionique
FR2774375B1 (fr) Procede perfectionne de fabrication d'anhydrides (meth)acryliques mixtes de haute purete
ES2042409A1 (es) Procedimiento para la preparacion de d-aminoacidos o derivados de d-aminoacidos.
BR9712690A (pt) Processo para a preparação de ivermectina